Create Alert
Watchlist

Wanbury

₹0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Fundamentals

Market Cap₹922Cr
ROE51.51%
P/E Ratio(TTM)21.45
EPS(TTM)13.07
P/B Ratio15.52
Dividend Yield0.00%
Industry P/E34.35
Book Value18.06
Debt to Equity2.98
Face Value10
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About WANBURY Limited

Wanbury Limited is an India-based pharmaceutical company. The Company is engaged in the business of pharmaceutical and related activities, including research. The Company operates through two divisions: the Active Pharmaceutical Ingredients (API) Business and the Domestic Formulations Business. The Company, through the Active Pharmaceutical Ingredients (API) Business, provides Metformin and Sertraline. Metformin is used for the treatment for type 2 diabetes and Sertraline is an anti-depressant. It has approximately 13 API products. It manufactures Metformin with over 8500 tons per year. Its products include Metformin HCL, Metformin DC/SR, Sertraline, Diphenhydramine, Mefenamic Acid, Glucosamine, Methoxsalen and Paroxetine. The Company's subsidiaries include Wanbury Holdings B. V. (Netherland), Wanbury Global FZE (UAE), Ningxia Wanbury Fine Chemicals Co. Ltd. (China) and Cantabria Pharma S. L. (Spain). ;
Parent OrganisationWANBURY Limited
Managing DirectorNA
NSE SymbolWANBURY

Shareholding Pattern

Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Retail And Others
58.78%
Promoters
39.63%
Foreign Institutions
1.59%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Cohance Lifesciences
NA
(0.00%)
104.04
JB Chemicals & Pharmaceuticals
NA
(0.00%)
39.17
Emcure Pharmaceuticals
NA
(0.00%)
34.76
Wockhardt
NA
(0.00%)
-186.92